Edition:
United States

Invion Ltd (IVX.AX)

IVX.AX on Australia Stock Exchange

0.00AUD
2 Dec 2016
Change (% chg)

$0.00 (+0.00%)
Prev Close
$0.00
Open
$0.00
Day's High
$0.00
Day's Low
$0.00
Volume
1,042,211
Avg. Vol
1,496,033
52-wk High
$0.01
52-wk Low
$0.00

IVX.AX

Chart for IVX.AX

About

Invion Limited is a clinical-stage life sciences (drug development) company. The Company is engaged in the completion of clinical development programs and targeted business development programs associated with its approximately three drug assets, such as INV102 (nadolol), INV103 (ala-Cpn10) and INV104 (zafirlukast). It focuses... (more)
No analyst recommendations are available for IVX.AX.

Overall

Beta: 2.67
Market Cap(Mil.): $4.95
Shares Outstanding(Mil.): 1,237.07
Dividend: --
Yield (%): --

Financials

  IVX.AX Industry Sector
P/E (TTM): -- 42.21 29.87
EPS (TTM): -0.00 -- --
ROI: -39.14 -1.09 14.95
ROE: -69.23 -2.39 16.29

Earnings vs. Estimates

No consensus analysis data available.